Abstract
Objectives Patients with osteoarthritis (OA) affecting multiple joints have poorer health outcomes than those without, yet most research examines isolated joints, leaving a gap in multi-joint disease. This study aimed to describe radiographically defined hip (rHOA) and knee OA (rKOA) within UK Biobank (UKB), exploring interrelationships across joints, and associations with joint pain, obesity, race and deprivation.
Methods Automated machine learning was applied to left and right hip and knee dual-energy X-ray absorptiometry scans. Radiographic OA (rOA) was defined as custom grades ≥2. Joint pain was assessed through self-reported questionnaires. Descriptive statistics summarised the population characteristics. Logistic regression models examined bilateral and cross-joint associations, as well as associations with joint pain. Adjustments were made for age, sex, race, height, weight and deprivation. Other models examined the associations between body size and OA.
Results Among 59,475 individuals (mean age 65 years; 52.8% female), rHOA prevalence was 4,098 (6.9%)) and 4,841 (8.1%) for the right and left joints, respectively. The corresponding estimates for rKOA were 3,750 (6.3%) and 4,220 (7.1%). Overall, increasing grades of rOA and number of joints affected were more strongly associated with joint pain. Regarding joint-interrelationships, bilateral associations were stronger at the knee, whereas cross-joint associations (hip-knee) were weaker. Associations with BMI and height differed between the hip and knee.
Conclusions Radiographic hip and knee OA exhibit distinct patterns of interrelationship, associations with symptoms and risk factors, suggesting heterogeneity in disease process and the need for joint-specific treatment.
What is already known on this topic?
Osteoarthritis (OA) commonly affects the hip and knee and is associated with pain and disability, with recognised risk factors such as age, obesity and deprivation.
Increasing interest in multi-joint OA challenges the traditional concept of lower-limb OA as a monoarthritis, but most research examines joints in isolation.
Genetic evidence suggests that hip and knee OA may differ in underlying mechanisms, yet population-scale comparisons are limited.
What this study adds?
Among 59,574 individuals, this study identifies that radiographic OA captures structurally and clinically relevant disease with increasing severity and greater number of joints affected, positively associated with chronic joint pain.
Radiographic hip and knee OA demonstrated strong bilateral but weaker cross-joint associations, indicating preferential within-joint symmetry.
Risk factors differed by anatomical site with BMI and weight strongly associated with knee OA and weakly associated with hip OA. Height showed the opposite associations.
How this study might affect research, practice or policy?
These findings support that hip and knee OA may partially represent different disease processes rather than a single condition.
Clinical practice should consider cumulative joint involvement and joint-specific risk factors.
Future research should consider the development of more targeted treatment to prevent multi-joint progression.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
BGF is supported by a Wellcome Trust Early Career Award (316390/Z/24/Z) and an Academy of Medical Sciences Starter Grant (SGL030\1057). RE, FS and MJ were supported by a Wellcome Trust collaborative award (209233/Z/17/Z). CL is funded by a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (223267/Z/21/Z). NCH is supported by UK Medical Research Council [MC_PC_21003; MC_PC_21001], the National Institute for Health and Care Research [as an NIHR Senior Investigator (NIHR305844), and through the NIHR Southampton Biomedical Research Centre (NIHR203319)]. AEN and LA are supported by NIH P30AR072580.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
UK Biobank obtained ethical approval from the National Information Governance Board for Health and Social Care and Northwest Multi-centre Research Ethics Committee (11/NW/0382). All participants provided informed consent for the collection and use of their data and for follow-up via linkage to electronic healthcare records.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
